Evaluation and Clinical Relevance of Plan Quality Indices in Intracavitary Brachytherapy for Cervical Cancer
F1000Research · 19.08.2026 · 14 · 882
DOI: 10.12688/f1000research.166604.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 19.08.2026. Verfasst von Abhishek Krishna und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Brachytherapy, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cervical cancer remains to be a significant health concern globally, with India contributing to nearly one-quarter of cases worldwide. Intracavitary brachytherapy (ICBT) combined with external beam radiotherapy (EBRT) is the standard of care, optimizing tumour dose while sparing normal tissues. Plan quality indices such as Dose Homogeneity Index (DHI), Overdose Index (OI), Dose Non-uniformity Ratio (DNR), and Conformity Index (COIN) are crucial in evaluating treatment plans, yet their predictive clinical relevance remains underexplored. Methodology In this Retrospective study, 84 patients with histologically confirmed cervical cancer undergoing definitive chemoradiation followed by CT-based HDR ICBT (Co-60) were evaluated. Plan indices were calculated per ICRU 89 and GEC-ESTRO guidelines. Correlation with tumour response (RECIST v1.1), toxicity (≥ grade 2 bladder/rectal), and clinical factors (FIGO stage, HRCTV volume, EQD2, BED, treatment duration) was assessed using t-tests, regression analyses, and Pearson’s correlation.
Results
Mean DHI was 0.403; OI 0.358; DNR 0.594; COIN 0.636. Higher DHI (p=0.019) and lower OI (p=0.004) were associated with tumour response; DNR and COIN were not significant. No plan index predicted ≥ grade 2 bladder or rectal toxicity. COIN correlated poorly with other indices. Multiple regression showed no consistent predictors of dosimetric indices. Logistic regression did not establish any index as a definitive predictor of 3-month response.
Conclusion
Plan quality indices provide useful quantitative insights into dose distribution in High dose rate intracavitary brachytherapy for cervical cancer. In this study, DHI and OI showed an association with early tumour response, while no significant correlation was observed between plan indices and treatment-related toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India.
ORCID-Profile: Abhishek Krishna, Bharat Sai Makkapati, Athiyamaan Ms, Dilson Lobo
Zitieren
APA
Krishna, A., Lobo, J. L., Ms, P., Makkapati, B. S., Ms, A., Srinivas, C., Banerjee, S., Sunny, J., Simon, P., & Lobo, D. (2026). Evaluation and Clinical Relevance of Plan Quality Indices in Intracavitary Brachytherapy for Cervical Cancer. F1000Research, 14, 882. https://doi.org/10.12688/f1000research.166604.2
Vancouver
Krishna A, Lobo JL, Ms P, Makkapati BS, Ms A, Srinivas C, et al. Evaluation and Clinical Relevance of Plan Quality Indices in Intracavitary Brachytherapy for Cervical Cancer. F1000Research. 2026;14:882. doi:10.12688/f1000research.166604.2
BibTeX
@article{Krishna2026,
author = {Krishna, Abhishek and Lobo, Juvie Leona and Ms, Pooja and Makkapati, Bharat Sai and Ms, Athiyamaan and Srinivas, Challapalli and Banerjee, Sourjya and Sunny, Johan and Simon, Paul and Lobo, Dilson},
title = {Evaluation and Clinical Relevance of Plan Quality Indices in Intracavitary Brachytherapy for Cervical Cancer},
journal = {F1000Research},
year = {2026},
volume = {14},
pages = {882},
doi = {10.12688/f1000research.166604.2}
}
EUVIMED